金世龙,黄中荣,陈华,等.HuH7细胞系CD13+CD133+HCC细胞分选及CSCs特性分析[J].第三军医大学学报,2012,34(16):1658. Jin Shilong,Huang Zhongrong,Chen Hua,et al.Sorting and cancer stem cell characteristic analysis of CD13+CD133+HCC cells in HuH7 cell line[J].J Third Mil Med Univ,2012,34(14):1658. [2]金世龙,余天雾,黄中荣,等.As2O3在HuH7及CD13+CD133+LCSCs增殖和分化中作用的初步观察[J].第三军医大学学报,2012,34(18):1857. Jin Shilong,Yu Tianwu,Huang Zhongrong,et al.Role of arsenic trioxide in proliferation of HuH7 cells and differentiation of CD13+CD133+ LCSCs[J].J Third Mil Med Univ,2012,34(14):1857. [3]庞林宾,王洪林,王晔飞,等.JAK2/STAT3通路在肝癌细胞侵袭及血管生成拟态中的作用[J].第三军医大学学报,2012,34(18):1862. Pang Linbin,Wang Honglin,Wang Yefei,et al.Role JAK2/STAT3 signaling pathway in invasion and vascular mimicry of liver cancer cells[J].J Third Mil Med Univ,2012,34(14):1862. [4]熊震,汤旭东,房殿春,等.人肝素酶RNAi序列的筛选及鉴定[J].第三军医大学学报,2007,29(20):1929. XIONG Zhen,TANG Xu-dong,FANG Dian-chun,et al.Screening and identification of heparanase RNAi sequence[J].J Third Mil Med Univ,2007,29(14):1929. [5]向征,张才全,汤为学.TSG101-siRNA对肝癌耐药细胞株QGY/CDDP的逆转作用[J].第三军医大学学报,2008,30(02):170. XIANG Zheng,ZHANG Cai-quan,TANG Wei-xue.Effect of tumor susceptibitity gene 101-siRNA eukaryotic expression vector and cisplatin on proliferation of QGY/CDDP[J].J Third Mil Med Univ,2008,30(14):170. [6]郑继军,王阁,邓婧,等.PD98059对肝癌HepG2细胞Tec信号转导作用的初步研究[J].第三军医大学学报,2006,28(02):136. [7]郑继军,王阁.肝癌粘附转移中相关整合素的作用研究现状[J].第三军医大学学报,2006,28(02):176. [8]张百红,贺佳,朱德增,等.一个新的肝癌分期系统的构建[J].第三军医大学学报,2006,28(03):253. [9]李宁,候丽娟.自体CIK细胞治疗肝癌患者的护理[J].第三军医大学学报,2006,28(05):485. [10]戴纪刚,肖颖彬,闵家新,等.高低转移小鼠肝癌细胞线粒体DNA遗传变异的研究[J].第三军医大学学报,2006,28(20):2030.
